Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Sohini Mondal

Amgen's Q3 2026 Earnings: What to Expect

With a market cap of $234.7 billion, Amgen Inc. (AMGN) is a leading biotechnology company that discovers, develops, manufactures, and delivers innovative medicines to address some of the world’s most challenging diseases. With more than 45 years of industry experience, the company leverages biology, advanced technology, and human genetic data to develop treatments across a broad range of areas, including cancer, heart disease, inflammatory conditions, rare diseases, and obesity.

The Thousand Oaks, California-based company is expected to release its fiscal Q3 2026 results after the market closes on Tuesday, Nov. 3. Ahead of this event, analysts expect AMGN to report an adjusted EPS of $5.72, up 1.4% from $5.64 in the prior year's quarter. It has surpassed Wall Street's bottom-line estimates in the past four quarters.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.